Key facts
- Slate Path Capital is a hedge fund based in New York, New York with 1 tracked portfolio company.
- Notable positions include City Therapeutics.
- Slate Path Capital has 2 funds on record, raising $2.4B across the 2 that report a size.
- Slate Path Capital reports $5.9B in regulatory assets under management across 2 private funds, per its SEC Form ADV (2026-03).
About Slate Path Capital
Founded in 2012
Registered with the SEC
Form ADV · 2026-03 · CRD 164751- Regulatory AUM
- $5.9B
- Private fund assets
- $12.0B
- Private funds
- 2 · 2 hedge
- Staff
- 25
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SLATE PATH CAPITAL LP).
Free account
See the whole book
- ·Watchlist + alerts for Slate Path Capital's activity
Create free account
No card required
Portfolio, priced
1 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| City Therapeutics | Drug Discovery | $285.5M | — |
Funds
2 recorded- Slate Path Partners LP2012$1.1B
- Slate Path Offshore Fund Ltd.2012$1.3B
$2.4B raised across the 2 funds that report a size
Frequently asked
- What companies does Slate Path Capital invest in?
- Slate Path Capital has 1 recorded portfolio companies, including City Therapeutics.
- What is Slate Path Capital's AUM?
- Slate Path Capital manages approximately $5.9B in assets.